No Data
No Data
Voyager Therapeutics up 8% Following Quarterly Beats
European Buy-rated Stocks That Trade Cheaply Vs. Their U.S. Peers - UBS
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths'
MacroGenics Inc (NASDAQ:MGNX) released interim data from the TAMARACK Phase 2 study of vobramitamab duocarmazine (vobra duo).TAMARACK is being conducted in previously treated patients with metastatic
Novartis Gets FDA Breakthrough Designation For Scemblix
Novartis Gets FDA Breakthrough Designation For Scemblix
Google DeepMind Develops Latest AI Model To Aid Scientists In Fighting Disease
Researchers at Alphabet Inc's (NASDAQ:GOOG) (NASDAQ:GOOGL) Google DeepMind have developed AlphaFold 3, an new artificial intelligence (AI) model.AlphaFold 3 can predict the structure and interactions
Cagent Vascular Appoints Chairman Brian Walsh to Expanded Role as Chief Executive Officer
Cagent Vascular announced today that Brian Walsh has been named Chief Executive Officer by the Cagent Vascular Board of Directors. He has served as Chairman of the Board since March 2018 and will continue in this